カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のロキサピン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Loxapine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19739）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19739
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のロキサピン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ロキサピン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のロキサピンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ロキサピン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・粉末、錠剤

用途別セグメントは次のように区分されます。
・病院、ドラッグストア

世界のロキサピン市場の主要な市場プレーヤーは以下のとおりです。
・Watson Laboratories、Teva、Mylan Pharmaceuticals、Grupo Ferrer Internacional、AOP Orphan Pharmaceuticals、Bago Pharmaceutical、Bioprojet Pharma、Galen Pharmaceuticals、Eisai、Wyeth、Delta Pharma、Swiss Pharmaceutical、Pfizer、Novartis

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ロキサピン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なロキサピンメーカーの企業概要、2019年～2022年までのロキサピンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なロキサピンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ロキサピンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのロキサピンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのロキサピン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびロキサピンの産業チェーンを掲載しています。
・第13、14、15章では、ロキサピンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ロキサピンの概要
- 種類別分析（2017年vs2021年vs2028年）：粉末、錠剤
- 用途別分析（2017年vs2021年vs2028年）：病院、ドラッグストア
- 世界のロキサピン市場規模・予測
- 世界のロキサピン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Watson Laboratories、Teva、Mylan Pharmaceuticals、Grupo Ferrer Internacional、AOP Orphan Pharmaceuticals、Bago Pharmaceutical、Bioprojet Pharma、Galen Pharmaceuticals、Eisai、Wyeth、Delta Pharma、Swiss Pharmaceutical、Pfizer、Novartis
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：粉末、錠剤
・用途別分析2017年-2028年：病院、ドラッグストア
・ロキサピンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ロキサピンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ロキサピンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ロキサピンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ロキサピンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Loxapine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Loxapine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Loxapine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Powder segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Loxapine include Watson Laboratories, Teva, Mylan Pharmaceuticals, Grupo Ferrer Internacional, and AOP Orphan Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Loxapine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Powder
Tablet
Market segment by Application can be divided into
Hospital
Drug Store
The key market players for global Loxapine market are listed below:
Watson Laboratories
Teva
Mylan Pharmaceuticals
Grupo Ferrer Internacional
AOP Orphan Pharmaceuticals
Bago Pharmaceutical
Bioprojet Pharma
Galen Pharmaceuticals
Eisai
Wyeth
Delta Pharma
Swiss Pharmaceutical
Pfizer
Novartis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Loxapine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Loxapine, with price, sales, revenue and global market share of Loxapine from 2019 to 2022.
Chapter 3, the Loxapine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Loxapine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Loxapine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Loxapine.
Chapter 13, 14, and 15, to describe Loxapine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Loxapine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Loxapine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Powder
1.2.3 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Loxapine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Loxapine Market Size & Forecast
1.4.1 Global Loxapine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Loxapine Sales in Volume (2017-2028)
1.4.3 Global Loxapine Price (2017-2028)
1.5 Global Loxapine Production Capacity Analysis
1.5.1 Global Loxapine Total Production Capacity (2017-2028)
1.5.2 Global Loxapine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Loxapine Market Drivers
1.6.2 Loxapine Market Restraints
1.6.3 Loxapine Trends Analysis
2 Manufacturers Profiles
2.1 Watson Laboratories
2.1.1 Watson Laboratories Details
2.1.2 Watson Laboratories Major Business
2.1.3 Watson Laboratories Loxapine Product and Services
2.1.4 Watson Laboratories Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Loxapine Product and Services
2.2.4 Teva Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Mylan Pharmaceuticals
2.3.1 Mylan Pharmaceuticals Details
2.3.2 Mylan Pharmaceuticals Major Business
2.3.3 Mylan Pharmaceuticals Loxapine Product and Services
2.3.4 Mylan Pharmaceuticals Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Grupo Ferrer Internacional
2.4.1 Grupo Ferrer Internacional Details
2.4.2 Grupo Ferrer Internacional Major Business
2.4.3 Grupo Ferrer Internacional Loxapine Product and Services
2.4.4 Grupo Ferrer Internacional Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AOP Orphan Pharmaceuticals
2.5.1 AOP Orphan Pharmaceuticals Details
2.5.2 AOP Orphan Pharmaceuticals Major Business
2.5.3 AOP Orphan Pharmaceuticals Loxapine Product and Services
2.5.4 AOP Orphan Pharmaceuticals Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bago Pharmaceutical
2.6.1 Bago Pharmaceutical Details
2.6.2 Bago Pharmaceutical Major Business
2.6.3 Bago Pharmaceutical Loxapine Product and Services
2.6.4 Bago Pharmaceutical Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bioprojet Pharma
2.7.1 Bioprojet Pharma Details
2.7.2 Bioprojet Pharma Major Business
2.7.3 Bioprojet Pharma Loxapine Product and Services
2.7.4 Bioprojet Pharma Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Galen Pharmaceuticals
2.8.1 Galen Pharmaceuticals Details
2.8.2 Galen Pharmaceuticals Major Business
2.8.3 Galen Pharmaceuticals Loxapine Product and Services
2.8.4 Galen Pharmaceuticals Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Eisai
2.9.1 Eisai Details
2.9.2 Eisai Major Business
2.9.3 Eisai Loxapine Product and Services
2.9.4 Eisai Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Wyeth
2.10.1 Wyeth Details
2.10.2 Wyeth Major Business
2.10.3 Wyeth Loxapine Product and Services
2.10.4 Wyeth Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Delta Pharma
2.11.1 Delta Pharma Details
2.11.2 Delta Pharma Major Business
2.11.3 Delta Pharma Loxapine Product and Services
2.11.4 Delta Pharma Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Swiss Pharmaceutical
2.12.1 Swiss Pharmaceutical Details
2.12.2 Swiss Pharmaceutical Major Business
2.12.3 Swiss Pharmaceutical Loxapine Product and Services
2.12.4 Swiss Pharmaceutical Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business
2.13.3 Pfizer Loxapine Product and Services
2.13.4 Pfizer Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Novartis
2.14.1 Novartis Details
2.14.2 Novartis Major Business
2.14.3 Novartis Loxapine Product and Services
2.14.4 Novartis Loxapine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Loxapine Breakdown Data by Manufacturer
3.1 Global Loxapine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Loxapine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Loxapine
3.4 Market Concentration Rate
3.4.1 Top 3 Loxapine Manufacturer Market Share in 2021
3.4.2 Top 6 Loxapine Manufacturer Market Share in 2021
3.5 Global Loxapine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Loxapine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Loxapine Market Size by Region
4.1.1 Global Loxapine Sales in Volume by Region (2017-2028)
4.1.2 Global Loxapine Revenue by Region (2017-2028)
4.2 North America Loxapine Revenue (2017-2028)
4.3 Europe Loxapine Revenue (2017-2028)
4.4 Asia-Pacific Loxapine Revenue (2017-2028)
4.5 South America Loxapine Revenue (2017-2028)
4.6 Middle East and Africa Loxapine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Loxapine Sales in Volume by Type (2017-2028)
5.2 Global Loxapine Revenue by Type (2017-2028)
5.3 Global Loxapine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Loxapine Sales in Volume by Application (2017-2028)
6.2 Global Loxapine Revenue by Application (2017-2028)
6.3 Global Loxapine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Loxapine Sales by Type (2017-2028)
7.2 North America Loxapine Sales by Application (2017-2028)
7.3 North America Loxapine Market Size by Country
7.3.1 North America Loxapine Sales in Volume by Country (2017-2028)
7.3.2 North America Loxapine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Loxapine Sales by Type (2017-2028)
8.2 Europe Loxapine Sales by Application (2017-2028)
8.3 Europe Loxapine Market Size by Country
8.3.1 Europe Loxapine Sales in Volume by Country (2017-2028)
8.3.2 Europe Loxapine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Loxapine Sales by Type (2017-2028)
9.2 Asia-Pacific Loxapine Sales by Application (2017-2028)
9.3 Asia-Pacific Loxapine Market Size by Region
9.3.1 Asia-Pacific Loxapine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Loxapine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Loxapine Sales by Type (2017-2028)
10.2 South America Loxapine Sales by Application (2017-2028)
10.3 South America Loxapine Market Size by Country
10.3.1 South America Loxapine Sales in Volume by Country (2017-2028)
10.3.2 South America Loxapine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Loxapine Sales by Type (2017-2028)
11.2 Middle East & Africa Loxapine Sales by Application (2017-2028)
11.3 Middle East & Africa Loxapine Market Size by Country
11.3.1 Middle East & Africa Loxapine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Loxapine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Loxapine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Loxapine
12.3 Loxapine Production Process
12.4 Loxapine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Loxapine Typical Distributors
13.3 Loxapine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Loxapine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Loxapine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Watson Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Watson Laboratories Major Business
Table 5. Watson Laboratories Loxapine Product and Services
Table 6. Watson Laboratories Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Loxapine Product and Services
Table 10. Teva Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Mylan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Pharmaceuticals Major Business
Table 13. Mylan Pharmaceuticals Loxapine Product and Services
Table 14. Mylan Pharmaceuticals Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Grupo Ferrer Internacional Basic Information, Manufacturing Base and Competitors
Table 16. Grupo Ferrer Internacional Major Business
Table 17. Grupo Ferrer Internacional Loxapine Product and Services
Table 18. Grupo Ferrer Internacional Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AOP Orphan Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. AOP Orphan Pharmaceuticals Major Business
Table 21. AOP Orphan Pharmaceuticals Loxapine Product and Services
Table 22. AOP Orphan Pharmaceuticals Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bago Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Bago Pharmaceutical Major Business
Table 25. Bago Pharmaceutical Loxapine Product and Services
Table 26. Bago Pharmaceutical Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Bioprojet Pharma Basic Information, Manufacturing Base and Competitors
Table 28. Bioprojet Pharma Major Business
Table 29. Bioprojet Pharma Loxapine Product and Services
Table 30. Bioprojet Pharma Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Galen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Galen Pharmaceuticals Major Business
Table 33. Galen Pharmaceuticals Loxapine Product and Services
Table 34. Galen Pharmaceuticals Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Eisai Basic Information, Manufacturing Base and Competitors
Table 36. Eisai Major Business
Table 37. Eisai Loxapine Product and Services
Table 38. Eisai Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Wyeth Basic Information, Manufacturing Base and Competitors
Table 40. Wyeth Major Business
Table 41. Wyeth Loxapine Product and Services
Table 42. Wyeth Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Delta Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Delta Pharma Major Business
Table 45. Delta Pharma Loxapine Product and Services
Table 46. Delta Pharma Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Swiss Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Swiss Pharmaceutical Major Business
Table 49. Swiss Pharmaceutical Loxapine Product and Services
Table 50. Swiss Pharmaceutical Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Pfizer Basic Information, Manufacturing Base and Competitors
Table 52. Pfizer Major Business
Table 53. Pfizer Loxapine Product and Services
Table 54. Pfizer Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Novartis Basic Information, Manufacturing Base and Competitors
Table 56. Novartis Major Business
Table 57. Novartis Loxapine Product and Services
Table 58. Novartis Loxapine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Loxapine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 60. Global Loxapine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Loxapine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Loxapine Production Capacity by Company, (K Units): 2020 VS 2021
Table 63. Head Office and Loxapine Production Site of Key Manufacturer
Table 64. Loxapine New Entrant and Capacity Expansion Plans
Table 65. Loxapine Mergers & Acquisitions in the Past Five Years
Table 66. Global Loxapine Sales by Region (2017-2022) & (K Units)
Table 67. Global Loxapine Sales by Region (2023-2028) & (K Units)
Table 68. Global Loxapine Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Loxapine Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Loxapine Sales by Type (2017-2022) & (K Units)
Table 71. Global Loxapine Sales by Type (2023-2028) & (K Units)
Table 72. Global Loxapine Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Loxapine Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Loxapine Price by Type (2017-2022) & (US$/Unit)
Table 75. Global Loxapine Price by Type (2023-2028) & (US$/Unit)
Table 76. Global Loxapine Sales by Application (2017-2022) & (K Units)
Table 77. Global Loxapine Sales by Application (2023-2028) & (K Units)
Table 78. Global Loxapine Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Loxapine Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Loxapine Price by Application (2017-2022) & (US$/Unit)
Table 81. Global Loxapine Price by Application (2023-2028) & (US$/Unit)
Table 82. North America Loxapine Sales by Country (2017-2022) & (K Units)
Table 83. North America Loxapine Sales by Country (2023-2028) & (K Units)
Table 84. North America Loxapine Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Loxapine Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Loxapine Sales by Type (2017-2022) & (K Units)
Table 87. North America Loxapine Sales by Type (2023-2028) & (K Units)
Table 88. North America Loxapine Sales by Application (2017-2022) & (K Units)
Table 89. North America Loxapine Sales by Application (2023-2028) & (K Units)
Table 90. Europe Loxapine Sales by Country (2017-2022) & (K Units)
Table 91. Europe Loxapine Sales by Country (2023-2028) & (K Units)
Table 92. Europe Loxapine Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Loxapine Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Loxapine Sales by Type (2017-2022) & (K Units)
Table 95. Europe Loxapine Sales by Type (2023-2028) & (K Units)
Table 96. Europe Loxapine Sales by Application (2017-2022) & (K Units)
Table 97. Europe Loxapine Sales by Application (2023-2028) & (K Units)
Table 98. Asia-Pacific Loxapine Sales by Region (2017-2022) & (K Units)
Table 99. Asia-Pacific Loxapine Sales by Region (2023-2028) & (K Units)
Table 100. Asia-Pacific Loxapine Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Loxapine Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Loxapine Sales by Type (2017-2022) & (K Units)
Table 103. Asia-Pacific Loxapine Sales by Type (2023-2028) & (K Units)
Table 104. Asia-Pacific Loxapine Sales by Application (2017-2022) & (K Units)
Table 105. Asia-Pacific Loxapine Sales by Application (2023-2028) & (K Units)
Table 106. South America Loxapine Sales by Country (2017-2022) & (K Units)
Table 107. South America Loxapine Sales by Country (2023-2028) & (K Units)
Table 108. South America Loxapine Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Loxapine Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Loxapine Sales by Type (2017-2022) & (K Units)
Table 111. South America Loxapine Sales by Type (2023-2028) & (K Units)
Table 112. South America Loxapine Sales by Application (2017-2022) & (K Units)
Table 113. South America Loxapine Sales by Application (2023-2028) & (K Units)
Table 114. Middle East & Africa Loxapine Sales by Region (2017-2022) & (K Units)
Table 115. Middle East & Africa Loxapine Sales by Region (2023-2028) & (K Units)
Table 116. Middle East & Africa Loxapine Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Loxapine Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Loxapine Sales by Type (2017-2022) & (K Units)
Table 119. Middle East & Africa Loxapine Sales by Type (2023-2028) & (K Units)
Table 120. Middle East & Africa Loxapine Sales by Application (2017-2022) & (K Units)
Table 121. Middle East & Africa Loxapine Sales by Application (2023-2028) & (K Units)
Table 122. Loxapine Raw Material
Table 123. Key Manufacturers of Loxapine Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Loxapine Typical Distributors
Table 127. Loxapine Typical Customers
List of Figures
Figure 1. Loxapine Picture
Figure 2. Global Loxapine Revenue Market Share by Type in 2021
Figure 3. Powder
Figure 4. Tablet
Figure 5. Global Loxapine Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Global Loxapine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Loxapine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Loxapine Sales (2017-2028) & (K Units)
Figure 11. Global Loxapine Price (2017-2028) & (US$/Unit)
Figure 12. Global Loxapine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Loxapine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Loxapine Market Drivers
Figure 15. Loxapine Market Restraints
Figure 16. Loxapine Market Trends
Figure 17. Global Loxapine Sales Market Share by Manufacturer in 2021
Figure 18. Global Loxapine Revenue Market Share by Manufacturer in 2021
Figure 19. Loxapine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Loxapine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Loxapine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Loxapine Sales Market Share by Region (2017-2028)
Figure 23. Global Loxapine Revenue Market Share by Region (2017-2028)
Figure 24. North America Loxapine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Loxapine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Loxapine Revenue (2017-2028) & (USD Million)
Figure 27. South America Loxapine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Loxapine Revenue (2017-2028) & (USD Million)
Figure 29. Global Loxapine Sales Market Share by Type (2017-2028)
Figure 30. Global Loxapine Revenue Market Share by Type (2017-2028)
Figure 31. Global Loxapine Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Loxapine Sales Market Share by Application (2017-2028)
Figure 33. Global Loxapine Revenue Market Share by Application (2017-2028)
Figure 34. Global Loxapine Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Loxapine Sales Market Share by Type (2017-2028)
Figure 36. North America Loxapine Sales Market Share by Application (2017-2028)
Figure 37. North America Loxapine Sales Market Share by Country (2017-2028)
Figure 38. North America Loxapine Revenue Market Share by Country (2017-2028)
Figure 39. United States Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Loxapine Sales Market Share by Type (2017-2028)
Figure 43. Europe Loxapine Sales Market Share by Application (2017-2028)
Figure 44. Europe Loxapine Sales Market Share by Country (2017-2028)
Figure 45. Europe Loxapine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Loxapine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Loxapine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Loxapine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Loxapine Revenue Market Share by Region (2017-2028)
Figure 55. China Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Loxapine Sales Market Share by Type (2017-2028)
Figure 62. South America Loxapine Sales Market Share by Application (2017-2028)
Figure 63. South America Loxapine Sales Market Share by Country (2017-2028)
Figure 64. South America Loxapine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Loxapine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Loxapine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Loxapine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Loxapine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Loxapine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Loxapine in 2021
Figure 76. Manufacturing Process Analysis of Loxapine
Figure 77. Loxapine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医薬品用容器閉鎖装置（CCS）市場2022年：市場規模予測（～2028年）
  • 世界のワクチン及び医薬品用ガラス瓶＆バイアル市場2022年：市場規模予測（～2028年）
  • 医薬品及び賦形剤のグローバル市場展望 2023年-2029年：中性脂肪、マンニトール、ソルビトール、ショ糖、ブドウ糖、でんぷん、その他
  • 医薬品用コールドチェーン物流の世界市場 2022年-2026年
  • 世界のバルデナフィル市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19739 )"世界のロキサピン市場2022年：市場規模予測（～2028年）" (英文：Global Loxapine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。